Landscape Capital Management L.L.C. lessened its position in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 80.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,369 shares of the company's stock after selling 136,496 shares during the quarter. Landscape Capital Management L.L.C.'s holdings in Envista were worth $644,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of NVST. Bryce Point Capital LLC bought a new position in Envista during the fourth quarter worth about $590,000. Massachusetts Financial Services Co. MA raised its stake in shares of Envista by 9.5% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,271,175 shares of the company's stock valued at $63,101,000 after purchasing an additional 283,415 shares during the period. Trexquant Investment LP acquired a new stake in Envista in the 4th quarter valued at approximately $5,982,000. Franklin Resources Inc. raised its holdings in shares of Envista by 72.6% in the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after purchasing an additional 2,882,844 shares during the last quarter. Finally, California Public Employees Retirement System boosted its holdings in Envista by 0.4% during the fourth quarter. California Public Employees Retirement System now owns 288,546 shares of the company's stock worth $5,566,000 after purchasing an additional 1,272 shares during the last quarter.
Envista Price Performance
Shares of Envista stock traded down $0.09 during midday trading on Friday, hitting $15.46. 2,446,183 shares of the company traded hands, compared to its average volume of 2,486,325. The firm's fifty day moving average price is $18.41 and its 200-day moving average price is $19.35. The stock has a market cap of $2.66 billion, a price-to-earnings ratio of -2.38, a PEG ratio of 1.27 and a beta of 1.12. Envista Holdings Co. has a 12 month low of $14.22 and a 12 month high of $23.00. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04.
Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, sell-side analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current year.
Analysts Set New Price Targets
A number of research analysts have weighed in on the company. UBS Group decreased their price target on Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Monday, March 10th. Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a research report on Thursday, March 6th. Jefferies Financial Group boosted their price objective on Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company set a $19.00 price objective on Envista in a research report on Saturday, March 8th. Finally, Piper Sandler boosted their price target on Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research note on Monday, February 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $20.18.
View Our Latest Research Report on NVST
Envista Company Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
